Onset of MELAS due to the m.3243A > G mutation is early if the large phenotypic variability is considered☆☆☆

Onset of MELAS due to the m.3243ANG mutation is early if the large phenotypic variability is considered ☆ , ☆☆ Keywords: mtDNA m.3243ANG MELAS Gene Mitochondrial disorder Stroke-like episode Letter to the Editor With interest we read the article by Sunde et al. about a female with MELAS syndrome with onset at age 49 years and four stroke-like episodes (SLEs) during the first 2 years who was followed-up for 5 years [1]. We have the following comments and concerns. The morphological equivalent of a SLE is a stroke-like lesion on cere-bral MRI during the acute stage. Only one MRI during the asymptomatic stage is described showing left occipital cystic encephalomalacia and white matter lesions [1]. No MRI figure is presented. The patient is reported to have had experienced four SLEs during the first 2 years after diagnosis [1]. Were ever typical abnormalities (DWI and ADC hyperintensity beyond a vascular territory) detected in the acute stage during any of these SLEs? Did these lesions change in a typical manner over time [2]? How did the authors exclude that the occipital lesion resulted from an ischemic stroke? We do not agree with the notion that MELAS was of late onset [1]. The patient is of short stature since childhood, hypothyroidism was detected at age 30 years, and hypoacusis started in her mid-30s [1]. Additionally , the patient had migraine, most likely since adolescence, and nausea. These are all typical manifestations of the m.3243A NG mutation, why physicians could have suspected a mitochondrial disorder (MID) much earlier [3]. When did nausea and migraine start? A mainstay of treating MIDs is the avoidance of mitochondrion-toxic drugs [4]. Why did the patient receive phenytoin, of which it is well-known that it has mitochondrion-toxic properties and should be avoided in MIDs [4]. Why does she require four antiepileptic drugs (AEDs)? Was ever a monotherapy with increased lamotrigine tried? The patient complains about generalised fatigue during follow-up [1]. Is levetiracetam or clonazepam the culprit? Overall, SLEs require MRI documentation, the patient might profit from modification of her AED-therapy, and all phenotypic manifestations should be considered when diagnosing MELAS.port: 5 year follow-up of adult late-onset mitochondrial encephalomyopathy with lactic acid and stroke-like episodes (MELAS), Mol.